Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


Generics and Patent Strategies 2013

13 May 2013 - 14 May 2013 - London, UK



Bookmark and Share


We are pleased to announce that registration is now open for the 16th annual conference, Generics and Patent Strategies, taking place in London from 13-14 May 2013. Don't miss out on attending. 

The conference will see world-renowned experts present the hottest topics and key challenges faced within the Generics industry today in combination with panel discussions, that will provide the latest updates on increasing profitability in a highly competitive market, how to overcome some of the IP issues faced when challenging patents and takes a detailed look at the pricing pressures surrounding an already saturated marketplace.

Reasons to attend this conference include:

Learn different strategies involved in regulatory affairs and how these can work to your advantage in Europe

Discuss how Originator companies are protecting their compounds and how you can strategically navigate around these issues

Identify ways to obtain a foothold in the Marketplace over your competitors: are value added Generics or Biosimilars the answer?

Discover how Patent litigation can work to your advantage when launching a first to market Generic

Determine the impacts of “Big Pharma” launching Generics into the Marketplace and what this means for smaller Generics companies


Register at www.pharma-generics.co.uk to secure your place!

Alternatively contact Jonathan Collins on +44 0 207 827 6734 or email on jcollins@smi-online.co.uk 



Further information
Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!